Year All202320222021202020192018201720162015 Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023 May 9, 2023 Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting May 2, 2023 Poseida Therapeutics to Present at BofA Securities 2023 Health Care Conference May 1, 2023 Poseida Therapeutics Appoints Rafael G. Amado, M.D., to Board of Directors April 13, 2023 Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 11, 2023 Poseida Therapeutics Appoints Kristin Yarema, Ph.D., as President, Cell Therapy April 11, 2023 Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2022 March 9, 2023 Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory Board March 1, 2023 Poseida Therapeutics Hosts Third Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations February 22, 2023 Poseida Therapeutics to Present at H.C. Wainwright Cell Therapy Virtual Conference February 14, 2023
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023 May 9, 2023
Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting May 2, 2023
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2022 March 9, 2023
Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory Board March 1, 2023
Poseida Therapeutics Hosts Third Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations February 22, 2023
